IP Library Granted Patent US 8,962,638
Granted Patent B2
US 8,962,638 · App. 13/627,747 · Granted Feb 24, 2015

Piperidine inhibitors of janus kinase 3

Inventors: Tadimeti Rao (San Diego, CA); Chengzhi Zhang (San Diego, CA)
Assignee: Auspex Pharmaceuticals, Inc.
C07D487/04
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,962,638
App. No.
13/627,747
Granted
Feb 24, 2015
Kind
B2
Abstract

The present invention relates to new piperidine inhibitors of Janus kinase 3 activity, pharmaceutical compositions thereof, and methods of use thereof.

Claims (3)

1. A method of treatment of a disorder selected from the group consisting of renal transplant rejection, rheumatoid arthritis, psoriasis, inflammatory bowel disease, dry eye syndrome, asthma, and transplant rejection comprising the administration, to a patient in need thereof, of a therapeutically effective amount of a compound having the structural formula

or a pharmaceutically acceptable salt thereof.

2. The method as recited in claim 1 wherein said disorder is rheumatoid arthritis.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 12, 2013
From: RAO, TADIMETI; ZHANG, CHENGZHI
To: AUSPEX PHARMACEUTICALS
Reel/Frame 029794/0321 →
Continuity (4)
Division 12763858 · Apr 20, 2010
Provisional Application 61300887 · Feb 3, 2010
Provisional Application 61170858 · Apr 20, 2009
Related Publication 20130040974A1 · Feb 14, 2013